Therapeutic Expertise
Project Capability
PRECLINICAL
Lab and Normal Study
PHASE 01
Safety study 20-80 People
PHASE 02
Safety study Identify Side effects Measure effectiveness 100-300 People
PHASE 03
Measure effectiveness Monitor side-effects 1000-3000 People
PHASE 04
Monitoring long-term side-effects